Authors:
Vos, K
van der Horst-Bruinsma, IE
Hazes, JMW
Breedveld, FC
le Cessie, S
Schreuder, GMT
de Vries, RRP
Zanelli, E
Citation: K. Vos et al., Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis, RHEUMATOLOG, 40(2), 2001, pp. 133-139
Authors:
Marsh, SGE
Bodmer, JG
Albert, ED
Bodmer, WF
Bontrop, RE
Dupont, S
Erlich, HA
Hansen, JA
Mach, B
Mayr, WR
Parham, P
Petersdorf, EW
Sasazuki, T
Schreuder, GMT
Strominger, JL
Svejgaard, A
Terasaki, PI
Citation: Sge. Marsh et al., Nomenclature for factors of the HLA system, 2000, EUR J IMM, 28(3), 2001, pp. 377-424
Authors:
Wirtz, PW
Roep, BO
Schreuder, GMT
van Doorn, PA
van Engelen, BGM
Kuks, JB
Twijnstra, A
de Visser, M
Visser, LH
Wokke, JH
Wintzen, AR
Verschuuren, JJ
Citation: Pw. Wirtz et al., HLA class I and II in Lambert-Eaton myasthenic syndrome without associatedtumor, HUMAN IMMUN, 62(8), 2001, pp. 809-813
Authors:
Schreuder, GMT
Hurley, CK
Marsh, SGE
Lau, M
Maiers, M
Kollman, C
Noreen, HJ
Citation: Gmt. Schreuder et al., The HLA dictionary 2001: A summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens, HUMAN IMMUN, 62(8), 2001, pp. 826-849
Authors:
Vos, K
Visser, H
Schreuder, GMT
de Vries, RRP
Zwinderman, AH
Breedveld, FC
Hazes, JMW
Zanelli, EH
Citation: K. Vos et al., Human leukocyte antigen-DQ and DR polymorphisms predict rheumatoid arthritis outcome better than DR alone, HUMAN IMMUN, 62(11), 2001, pp. 1217-1225
Authors:
Zanelli, E
Jones, G
Pascual, M
Eerligh, P
van der Slik, AR
Zwinderman, AH
Verduyn, W
Schreuder, GMT
Roovers, E
Breedveld, FC
de Vries, RRP
Martin, J
Giphart, MJ
Citation: E. Zanelli et al., The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci, HUMAN IMMUN, 62(1), 2001, pp. 75-84
Authors:
Snijders, A
Elferink, DG
Geluk, A
van der Zanden, AL
Vos, K
Schreuder, GMT
Breedveld, FC
de Vries, RRP
Zanelli, EH
Citation: A. Snijders et al., An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs, J IMMUNOL, 166(8), 2001, pp. 4987-4993
Authors:
Schreuder, GMT
Hurley, CK
Marsh, SGE
Lau, M
Maiers, M
Kollman, C
Noreen, HJ
Citation: Gmt. Schreuder et al., The HLA Dictionary 2001: a summary of HLA-A, -B, -C,-DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens, TISSUE ANTI, 58(2), 2001, pp. 109-140
Authors:
Anholts, JDH
Kemps-Mols, B
Verduijn, W
Oudshoorn, M
Schreuder, GMT
Citation: Jdh. Anholts et al., Three newly identified HLA-B alleles: B5124, B*5306, B*5307 and confirmation of B*0809 and B*5606, TISSUE ANTI, 58(1), 2001, pp. 38-41
Citation: Gj. Izaks et al., The effect of geographic origin on the frequency of HLA antigens and theirassociation with ageing, EUR J IMM, 27(2), 2000, pp. 87-92
Authors:
Rood, MJ
Van Krugten, MV
Zanelli, E
Van der Linden, MW
Keijsers, V
Schreuder, GMT
Verduyn, W
Westendorp, RGJ
De Vries, RRP
Breedveld, FC
Verweij, CL
Huizinga, TWJ
Citation: Mj. Rood et al., TNF-308A and HLA-DR3 alleles contribute independently to susceptibility tosystemic lupus erythematosus, ARTH RHEUM, 43(1), 2000, pp. 129-134
Authors:
Anholts, JDH
Verduijn, W
Drabbels, J
Mulder, A
Doxiadis, IIN
Schreuder, GMT
Citation: Jdh. Anholts et al., Identification of two new alleles HLA-DRB10312, DRB1*0432 and of a DRB3-negative DRB1*1313-positive haplotype, TISSUE ANTI, 56(1), 2000, pp. 87-89
Authors:
van der Horst-Bruinsma, IE
Huizinga, TWJ
Lagaay, EM
Hazes, JMW
Breedveld, FC
Schreuder, GMT
Tomson, TAS
Zwinderman, AH
van Rood, JJ
de Vries, RRP
Citation: Ie. Van Der Horst-bruinsma et al., The influence of a partially HLA-matched blood transfusion on the disease activity of rheumatoid arthritis, RHEUMATOLOG, 38(1), 1999, pp. 53-58
Authors:
Bodmer, JG
Marsh, SGE
Albert, ED
Bodmer, WF
Bontrop, RE
Dupont, B
Erlich, HA
Hansen, JA
Mach, B
Mayr, WR
Parham, P
Petersdorf, EW
Sasazuki, T
Schreuder, GMT
Strominger, JL
Svejgaard, A
Terasaki, PI
Citation: Jg. Bodmer et al., Nomenclature for factors of the HLA system, 1998, EUR J IMM, 26(2-3), 1999, pp. 81-116
Authors:
Bodmer, JG
Marsh, SGE
Albert, ED
Bodmer, WF
Bontrop, RE
Dupont, B
Erlich, HA
Hansen, JA
Mach, B
Mayr, WR
Parham, P
Petersdorf, EW
Sasazuki, T
Schreuder, GMT
Strominger, JL
Svejgaard, A
Terasaki, PI
Citation: Jg. Bodmer et al., Nomenclature for Factors of the HLA System, 1998, HUMAN IMMUN, 60(4), 1999, pp. 361-395
Authors:
van der Horst-Bruinsma, IE
Visser, H
Hazes, JMW
Breedveld, FC
Verduyn, W
Schreuder, GMT
de Vries, RRP
Zanelli, E
Citation: Ie. Van Der Horst-bruinsma et al., HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis, HUMAN IMMUN, 60(2), 1999, pp. 152-158
Authors:
Schreuder, GMT
Hurley, CK
Marsh, SGE
Lau, M
Maiers, M
Kollman, C
Noreen, H
Citation: Gmt. Schreuder et al., The HLA dictionary 1999: A summary of HLA-A, -B, -C,-DRB1/3/4/5,-DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens, HUMAN IMMUN, 60(11), 1999, pp. 1157-1181
Authors:
Thole, JER
Janson, AAM
Cornelisse, Y
Schreuder, GMT
Wieles, B
Naafs, B
de Vries, RRP
Ottenhoff, THM
Citation: Jer. Thole et al., HLA-class II-associated control of antigen recognition by T cells in leprosy: A prominent role for the 30/31-kDa antigens, J IMMUNOL, 162(11), 1999, pp. 6912-6918
Authors:
Ressing, ME
de Jong, JH
Brandt, RMP
Drijfhout, JW
Benckhuijsen, WE
Schreuder, GMT
Offringa, R
Kast, WM
Melief, CJM
Citation: Me. Ressing et al., Differential binding of viral peptides to HLA-A2 alleles. Implications forhuman papillomavirus type 16 E7 peptide-based vaccination against cervicalcarcinoma, EUR J IMMUN, 29(4), 1999, pp. 1292-1303